Project Grant HT94252310972
Award Date 9/30/23
Completion Date 9/29/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
College Station, TX 77843, USA
Similar Awards
- The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
- The federal Project Grant award of $999,784.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research on "Circadian Dysregulation as a Risk Factor for Age-Related Cognitive Impairment" at Texas A&M University System Health Science Center (TAMU HSC). The research aims to investigate the relationship between disruptions in the body's circadian rhythms and the development of age-related cognitive decline. TAMU...
- The Defense Health Agency awarded a $767,558 Project Grant to the Texas A&M University System Health Science Center to conduct research on "GANAXOLONE AS REPURPOSED TREATMENT FOR GULF WAR ILLNESS" under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 30, 2024 to September 29, 2027, will fund innovative biomedical research to explore the use of the drug ganaxolone as a potential treatment for Gulf War Illness,...
- This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August...
- The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
- This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
- The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
- The Department of Defense awarded a $748,784 Project Grant to the University of Texas Health Science Center at Houston (UTHealth) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, will support research to detect and characterize alpha-synuclein aggregates in patients with Alzheimer's disease and related dementias. Through this project, UTHealth, the prime grantee, will conduct specialized laboratory testing, data...
- This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $713,277 to Boston University Medical Campus to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The award will support the project from September 1, 2024 through August 31, 2027. As part of this...